Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
about
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in miceCell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytesEffects of heparin on the uptake of lipoprotein lipase in rat liverHepatitis E PathogenesisApolipoprotein E: from cardiovascular disease to neurodegenerative disordersKinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in HumansHerpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's DiseaseApolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature reviewTopology of human apolipoprotein E3 uniquely regulates its diverse biological functionsDynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise trainingAPOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectiveApolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionBiophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemiaA computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolismHeparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.Mouse models of atherosclerosis: a historical perspective and recent advances.Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearanceSmall-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathologyAdipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.Analysis of mass spectrometry data from the secretome of an explant model of articular cartilage exposed to pro-inflammatory and anti-inflammatory stimuli using machine learning.ApoE plasma levels and risk of cardiovascular mortality in old ageHeparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearancePostprandial lipoproteins and cardiovascular disease risk in diabetes mellitus.LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxinsDefective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient miceRegulated Entry of Hepatitis C Virus into Hepatocytes.Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.Adipose tissue gene expression of factors related to lipid processing in obesity.Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells.The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewAlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterolBinding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.
P2860
Q24647376-A31F03A5-A50E-4EC9-A9BE-C2BC423DF643Q24791488-5979514D-10AC-49B6-AF1F-6CDD51005EDFQ24799944-8C1AB0E3-90EC-4632-9E37-AF1DAA5080A7Q26741395-93ECC121-D7B7-4FCE-A616-29D1ECDFE9A3Q26747482-84858210-A5ED-4FA6-BBFA-1F454E5BDCBFQ26774776-DBA730E1-774B-4665-94CA-F2349D2BDEA7Q26781578-3688EB1B-3650-4725-85F7-B9940C09D48DQ27491003-1CF9C8F9-AFD1-442D-9B73-C689D97CA906Q27672294-113388F6-FE11-4012-9100-3D6F56713F87Q28073180-6B5C4A1F-9A19-4DC5-A90E-A71BB5CBE7FCQ28085213-A0FAF2A0-2C68-4CC5-B70F-EA554619082CQ28284354-0E558A3C-BA9A-4CA8-B657-82615475D234Q28477741-734996D7-5AE3-4CAE-B1FC-EEF16EBCC88FQ28538300-92300FF3-F591-452C-B974-04F8FA559EC4Q29976923-98AADD90-18FA-49D6-B2E0-3D1A451A92FCQ30238973-D1A7D670-7C97-44C4-83D0-60307922FF66Q30274556-01BB738C-2923-417D-805B-B212D9F14049Q30421643-DDCC017B-095F-479A-AE47-847EA7CA28FDQ30480233-3419782D-97A9-4EF9-884E-6F5441A08013Q30491848-CAF6C904-D57D-45F1-BD14-1DE4FA921A56Q30535428-EAD1ECBB-EB59-44D7-9A86-A1B2E76DC0F1Q30561348-BC964F25-48F9-48DA-9153-DD0EF6B323EBQ33242076-4D789587-347C-428B-A6A1-096047E5F014Q33581252-5BF16081-76B4-4B0A-A67E-45F8BC9E6195Q33651279-F2674009-B904-4B78-B19E-5CE06C8035C8Q33674269-6EA20062-9EE2-4918-83E1-AEE4CBD83C91Q33697550-D469CF20-654E-424E-B889-63C5CFA8C026Q33753913-D5CE3987-744B-477F-B0A0-467F09EBA696Q33887783-E6443582-0792-485B-AFE6-F3F2D1420AFBQ33960315-BDFAB8B0-1E5D-40D7-B97A-7853372EC313Q34025149-5A5B4CF6-CBE7-4042-9007-7FB883ECA06AQ34037803-B3C252F7-2CB6-4493-9DF6-473AD292C05EQ34129368-7A1479C6-F15B-47BF-A490-514AF0A5FD03Q34190545-A5B097E2-3647-4294-9BC5-2BC483ADE988Q34238630-714A1AAA-01A4-4965-97C9-93CB2CF09832Q34286579-EBA8E2F4-1AE3-4339-BDB1-01FD5E0F4104Q34305393-40DFF978-8695-4FB0-80F3-D8EA68FBE490Q34311144-0BA06867-E764-44CB-897A-0A7F270B330EQ34315738-4CF0E547-75D2-4665-BCE1-F480D88754AFQ34329102-87224E1B-7664-42E2-85F4-FC9235106B79
P2860
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@ast
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@en
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@nl
type
label
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@ast
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@en
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@nl
prefLabel
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@ast
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@en
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@nl
P3181
P1476
Remnant lipoprotein metabolism ...... eoglycans and apolipoprotein E
@en
P3181
P407
P577
1999-01-01T00:00:00Z